MM-362 Multiple Myeloma Oligosecretory Relapse: A Cross-Sectional Historical Cohort Study

MM can infrequently present as oligosecretory disease. Data regarding the clinical phenotype of oligosecretory relapse (OSR) are lacking. We report the characteristics and outcomes of OSR. We included all MM patients with measurable disease at diagnosis who developed an OSR between January 2016 and...

Full description

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2023-09, Vol.23, p.S493-S493
Main Authors: Cohen, Inbar, Vaxman, Iuliana, Zamir, Itai, Fridberg, Gil, Shragai, Tamir, Trestman, Svetlana, Baran, Tomer Ziv, Luttwak, Efrat, Shmuel, Ronit, Melamed, Natan, Avivi, Irit, Raanani, Pia, Dispenzieri, Angela, Gertz, Morie A., Cohen, Yael C.
Format: Article
Language:English
Subjects:
oligosecretory
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:MM can infrequently present as oligosecretory disease. Data regarding the clinical phenotype of oligosecretory relapse (OSR) are lacking. We report the characteristics and outcomes of OSR. We included all MM patients with measurable disease at diagnosis who developed an OSR between January 2016 and July 2020, at Mayo Clinic and TLVMC. OSR was defined as M-protein
ISSN:2152-2650
2152-2669
DOI:10.1016/S2152-2650(23)01442-8